CERTARA INC. - COMMON STOCK

Certara Appoints James E. Cashman III as Chairman of Board of Directors

08 Nov 2021 16:30:00 By Nasdaq GlobeNewswire

Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

03 Nov 2021 08:00:00 By Nasdaq GlobeNewswire

Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services

28 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

25 Oct 2021 16:30:00 By Nasdaq GlobeNewswire

Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021

19 Oct 2021 08:00:02 By Nasdaq GlobeNewswire

Certara Appoints Patrick F. Smith to President of Integrated Drug Development

12 Oct 2021 08:00:02 By Nasdaq GlobeNewswire

Certara Appoints Drayton T. Virkler as Chief Commercial Officer

05 Oct 2021 08:00:02 By Nasdaq GlobeNewswire

Certara Completes Acquisition of Pinnacle 21

04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process

30 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Announces New Clinical Science Group and Adds Senior Scientific Experts

22 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation

20 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

13 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Announces Pricing of Public Offering of Common Stock

08 Sep 2021 21:00:57 By Nasdaq GlobeNewswire

Certara Announces Proposed Public Offering of Common Stock

03 Sep 2021 06:10:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

31 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Reports Second Quarter 2021 Financial Results

05 Aug 2021 16:20:00 By Nasdaq GlobeNewswire

Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data

05 Aug 2021 16:15:00 By Nasdaq GlobeNewswire

Mubadala Invests in Global Biosimulation Leader Certara

27 Jul 2021 17:02:57 By Nasdaq GlobeNewswire

Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19

23 Jul 2021 17:30:00 By Nasdaq GlobeNewswire

Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members

15 Jul 2021 16:30:00 By Nasdaq GlobeNewswire